Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06101277
- Conditions
- Adenocarcinoma, Appendiceal Cancer, Appendiceal Neoplasms, +28 more
- Locations
-
- University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
NCT05849480
- Conditions
- Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +8 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
NCT06819215
- Conditions
- Adnexal Diseases, Biliary Cancer, Biliary Tract Diseases, +43 more
- Locations
-
- Cancer Hospital of Shandong First Medical university Jinan, Shandong, China
NCT05517811
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Biliary Cancer, +34 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
NCT00924027
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +30 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05462314
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +32 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
- Locations
-
- Western Regional Medical Center at Cancer Treatment Centers of America Goodyear, Arizona, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Highlands Oncology Group Springdale, Arkansas, United States
- Science 37, Inc Culver City, California, United States
NCT02703714
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT01099631
- Conditions
- Adenocarcinoma, Biliary Cancer, Biliary Tract Diseases, +14 more
- Locations
-
- Edward W. Greeno, MD Minneapolis, Minnesota, United States
NCT00948935
- Conditions
- Adenocarcinoma, Biliary Cancer, Biliary Tract Diseases, +9 more
- Locations
-
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01853618
- Conditions
- Adenocarcinoma, Biliary Cancer, Biliary Tract Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02626195
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +12 more
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea
NCT01401894
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01661114
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT02930252
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
- Locations
-
- General Hospital sanremo Sanremo, Imperia, Italy
NCT01838109
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +26 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00551096
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
NCT00626158
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Huntsman Cancer Center, University of Utah Salt Lake City, Utah, United States
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
NCT04644068
- Conditions
- Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
- Research Site Oklahoma City, Oklahoma, United States
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified